Skip to main content
Top
Published in: Supportive Care in Cancer 9/2008

01-09-2008 | Original Article

Patient–oncologist communication in advanced cancer: predictors of patient perception of prognosis

Authors: Tracy M. Robinson, Stewart C. Alexander, Margie Hays, Amy S. Jeffreys, Maren K. Olsen, Keri L. Rodriguez, Kathryn I. Pollak, Amy P. Abernethy, Robert Arnold, James A. Tulsky

Published in: Supportive Care in Cancer | Issue 9/2008

Login to get access

Abstract

Goals of work

Advanced cancer patients’ perceptions of prognosis, which are often overly optimistic compared to oncologist estimates, influence treatment preferences. The predictors of patients’ perceptions and the effect of oncologist communication on patient understanding are unclear. This study was designed to identify the communication factors that influence patient–oncologist concordance about chance of cure.

Materials and methods

We analyzed audiorecorded encounters between 51 oncologists and 141 advanced cancer patients with good (n = 69) or poor (n = 72) concordance about chance of cure. Encounters were coded for communication factors that might influence oncologist–patient concordance, including oncologist statements of optimism and pessimism.

Main results

Oncologists made more statements of optimism (mean = 3.3 per encounter) than statements of pessimism (mean = 1.2 per encounter). When oncologists made at least one statement of pessimism, patients were more likely to agree with their oncologist’s estimated chance of cure (OR = 2.59, 95%CI = 1.31–5.12). Statements of optimism and uncertainty were not associated with an increased likelihood that patients would agree or disagree with their oncologists about chance of cure.

Conclusions

Communication of pessimistic information to patients with advanced cancer increases the likelihood that patients will report concordant prognostic estimates. Communication of optimistic information does not have any direct effect. The best communication strategy to maximize patient knowledge for informed decision making while remaining sensitive to patients’ emotional needs may be to emphasize optimistic aspects of prognosis while also consciously and clearly communicating pessimistic aspects of prognosis.
Literature
1.
go back to reference Bradley EH, Hallemeier AG, Fried TR, Johnson-Hurzeler R, Cherlin EJ, Kasl SV et al (2001) Documentation of discussions about prognosis with terminally ill patients. Am J Med 111:218–23PubMedCrossRef Bradley EH, Hallemeier AG, Fried TR, Johnson-Hurzeler R, Cherlin EJ, Kasl SV et al (2001) Documentation of discussions about prognosis with terminally ill patients. Am J Med 111:218–23PubMedCrossRef
2.
go back to reference Butow PN, Maclean M, Dunn SM, Tattersall MH, Boyer MJ (1997) The dynamics of change: cancer patients’ preferences for information, involvement and support. Ann Oncol 8:857–863PubMedCrossRef Butow PN, Maclean M, Dunn SM, Tattersall MH, Boyer MJ (1997) The dynamics of change: cancer patients’ preferences for information, involvement and support. Ann Oncol 8:857–863PubMedCrossRef
3.
go back to reference Butow PN, Dowsett S, Hagerty R, Tattersall MH (2002) Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer 10:161–168PubMedCrossRef Butow PN, Dowsett S, Hagerty R, Tattersall MH (2002) Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer 10:161–168PubMedCrossRef
4.
go back to reference Carver CS (1997) You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med 4:92–100PubMedCrossRef Carver CS (1997) You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med 4:92–100PubMedCrossRef
5.
go back to reference Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 320:469–472PubMedCrossRef Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 320:469–472PubMedCrossRef
6.
go back to reference Clayton JM, Butow PN, Arnold RM, Tattersall MH (2005) Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer 103:1965–1975PubMedCrossRef Clayton JM, Butow PN, Arnold RM, Tattersall MH (2005) Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer 103:1965–1975PubMedCrossRef
7.
go back to reference Fallowfield LJ, Jenkins VA, Beveridge HA (2002) Truth may hurt but deceit hurts more: communication in palliative care. Palliat Med 16:297–303PubMedCrossRef Fallowfield LJ, Jenkins VA, Beveridge HA (2002) Truth may hurt but deceit hurts more: communication in palliative care. Palliat Med 16:297–303PubMedCrossRef
8.
go back to reference Fried TR, Bradley EH, Towle VR, Allore H (2002) Understanding the treatment preferences of seriously ill patients. N Engl J Med 346:1061–1066PubMedCrossRef Fried TR, Bradley EH, Towle VR, Allore H (2002) Understanding the treatment preferences of seriously ill patients. N Engl J Med 346:1061–1066PubMedCrossRef
9.
go back to reference Fried TR, Bradley EH, O’Leary J (2003) Prognosis communication in serious illness: perceptions of older patients, caregivers, and clinicians. J Am Geriatr Soc 51:1398–403PubMedCrossRef Fried TR, Bradley EH, O’Leary J (2003) Prognosis communication in serious illness: perceptions of older patients, caregivers, and clinicians. J Am Geriatr Soc 51:1398–403PubMedCrossRef
10.
go back to reference Gattellari M, Butow PN, Tattersall MH, Dunn SM, MacLeod CA (1999) Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol 10:39–46PubMedCrossRef Gattellari M, Butow PN, Tattersall MH, Dunn SM, MacLeod CA (1999) Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol 10:39–46PubMedCrossRef
11.
go back to reference Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J et al (2003) A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 327:195PubMedCrossRef Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J et al (2003) A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 327:195PubMedCrossRef
12.
go back to reference Gordon EJ, Daugherty CK (2003) ‘Hitting you over the head’: oncologists’ disclosure of prognosis to advanced cancer patients. Bioethics 17:142–168PubMedCrossRef Gordon EJ, Daugherty CK (2003) ‘Hitting you over the head’: oncologists’ disclosure of prognosis to advanced cancer patients. Bioethics 17:142–168PubMedCrossRef
13.
go back to reference Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N et al (2004) Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 22:1721–1730PubMedCrossRef Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N et al (2004) Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 22:1721–1730PubMedCrossRef
14.
go back to reference Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N et al (2005) Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol 23:1278–1288PubMedCrossRef Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N et al (2005) Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol 23:1278–1288PubMedCrossRef
15.
go back to reference Haidet P, Hamel MB, Davis RB, Wenger N, Reding D, Kussin PS et al (1998) Outcomes, preferences for resuscitation, and physician–patient communication among patients with metastatic colorectal cancer. SUPPORT Investigators. Study to understand prognoses and preferences for outcomes and risks of treatments. Am J Med 105:222–229PubMedCrossRef Haidet P, Hamel MB, Davis RB, Wenger N, Reding D, Kussin PS et al (1998) Outcomes, preferences for resuscitation, and physician–patient communication among patients with metastatic colorectal cancer. SUPPORT Investigators. Study to understand prognoses and preferences for outcomes and risks of treatments. Am J Med 105:222–229PubMedCrossRef
16.
go back to reference Helft PR (2005) Necessary collusion: prognostic communication with advanced cancer patients. J Clin Oncol 23:3146–3150PubMedCrossRef Helft PR (2005) Necessary collusion: prognostic communication with advanced cancer patients. J Clin Oncol 23:3146–3150PubMedCrossRef
17.
go back to reference Jenkins V, Fallowfield L, Saul J (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84:48–51PubMedCrossRef Jenkins V, Fallowfield L, Saul J (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84:48–51PubMedCrossRef
18.
19.
go back to reference Koropchak CM, Pollak KI, Arnold R, Alexander SC, Skinner CS, Olsen M et al (2006) Studying communication in oncologist–patient encounters: the SCOPE Trial. Palliat Med 20:813–819PubMedCrossRef Koropchak CM, Pollak KI, Arnold R, Alexander SC, Skinner CS, Olsen M et al (2006) Studying communication in oncologist–patient encounters: the SCOPE Trial. Palliat Med 20:813–819PubMedCrossRef
20.
go back to reference Lamont EB, Christakis NA (2001) Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134:1096–1105PubMed Lamont EB, Christakis NA (2001) Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134:1096–1105PubMed
21.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
22.
go back to reference Lobb EA, Kenny DT, Butow PN, Tattersall MH (2001) Women’s preferences for discussion of prognosis in early breast cancer. Health Expect 4:48–57PubMedCrossRef Lobb EA, Kenny DT, Butow PN, Tattersall MH (2001) Women’s preferences for discussion of prognosis in early breast cancer. Health Expect 4:48–57PubMedCrossRef
23.
go back to reference Mackillop WJ, Stewart WE, Ginsburg AD, Stewart SS (1988) Cancer patients’ perceptions of their disease and its treatment. Br J Cancer 58:355–358PubMed Mackillop WJ, Stewart WE, Ginsburg AD, Stewart SS (1988) Cancer patients’ perceptions of their disease and its treatment. Br J Cancer 58:355–358PubMed
24.
go back to reference Mackillop WJ, Quirt CF (1997) Measuring the accuracy of prognostic judgments in oncology. J Clin Epidemiol 50:21–29PubMedCrossRef Mackillop WJ, Quirt CF (1997) Measuring the accuracy of prognostic judgments in oncology. J Clin Epidemiol 50:21–29PubMedCrossRef
25.
go back to reference Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB 3rd, Castel L (2003) Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician–patient communication. J Clin Oncol 21:2589–2596PubMedCrossRef Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB 3rd, Castel L (2003) Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician–patient communication. J Clin Oncol 21:2589–2596PubMedCrossRef
26.
go back to reference Miyaji NT (1993) The power of compassion: truth-telling among American doctors in the care of dying patients. Soc Sci Med 36:249–264PubMedCrossRef Miyaji NT (1993) The power of compassion: truth-telling among American doctors in the care of dying patients. Soc Sci Med 36:249–264PubMedCrossRef
27.
28.
go back to reference Quirt CF, Mackillop WJ, Ginsburg AD, Sheldon L, Brundage M, Dixon P et al (1997) Do doctors know when their patients don’t? A survey of doctor–patient communication in lung cancer. Lung Cancer 18:1–20PubMedCrossRef Quirt CF, Mackillop WJ, Ginsburg AD, Sheldon L, Brundage M, Dixon P et al (1997) Do doctors know when their patients don’t? A survey of doctor–patient communication in lung cancer. Lung Cancer 18:1–20PubMedCrossRef
29.
go back to reference Rodriguez KL, Gambino FJ, Hagerty R, Butow P, Arnold RM (2007) Pushing up daisies: implicit and explicit language in oncologist–patient communication about death. Support Care Cancer 15:153–161PubMedCrossRef Rodriguez KL, Gambino FJ, Hagerty R, Butow P, Arnold RM (2007) Pushing up daisies: implicit and explicit language in oncologist–patient communication about death. Support Care Cancer 15:153–161PubMedCrossRef
30.
go back to reference Siminoff LA, Fetting JH, Abeloff MD (1989) Doctor–patient communication about breast cancer adjuvant therapy. J Clin Oncol 7:1192–2000PubMed Siminoff LA, Fetting JH, Abeloff MD (1989) Doctor–patient communication about breast cancer adjuvant therapy. J Clin Oncol 7:1192–2000PubMed
31.
go back to reference The AM, Hak T, Koeter G, van Der Wal G (2000) Collusion in doctor–patient communication about imminent death: an ethnographic study. BMJ 321:1376–1381PubMedCrossRef The AM, Hak T, Koeter G, van Der Wal G (2000) Collusion in doctor–patient communication about imminent death: an ethnographic study. BMJ 321:1376–1381PubMedCrossRef
32.
go back to reference Weeks JC, Cook EF, O’Day SJ, Peterson LM, Wenger N, Reding D et al (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279:1709–1704PubMedCrossRef Weeks JC, Cook EF, O’Day SJ, Peterson LM, Wenger N, Reding D et al (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279:1709–1704PubMedCrossRef
Metadata
Title
Patient–oncologist communication in advanced cancer: predictors of patient perception of prognosis
Authors
Tracy M. Robinson
Stewart C. Alexander
Margie Hays
Amy S. Jeffreys
Maren K. Olsen
Keri L. Rodriguez
Kathryn I. Pollak
Amy P. Abernethy
Robert Arnold
James A. Tulsky
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2008
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0372-2

Other articles of this Issue 9/2008

Supportive Care in Cancer 9/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine